FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4214897071> ?p ?o ?g. }

• W4214897071 endingPage "436" @default.
• W4214897071 startingPage "429" @default.
• W4214897071 abstract "Diabetes is a common comorbidity in the U.S. and is associated with adverse outcomes in a variety of disease processes. Other cancer specialties have shown an association of diabetes with poor oncologic outcomes. We hypothesized that pathologic complete response (pCR) would be less likely among diabetic patients with esophageal cancer who underwent neoadjuvant chemoradiation therapy followed by esophagectomy resulting in worse overall survival (OS). We performed a retrospective chart review at 2 high-volume academic hospitals of all patients with esophageal cancer who received neoadjuvant chemoradiation therapy followed by esophagectomy from 2010-2019. Patients were excluded if they had histology other than squamous cell carcinoma or adenocarcinoma, did not receive multi-agent chemotherapy or received a radiation dose <39.6 Gy. The primary outcome of interest was pCR and secondary outcome was OS. Multivariable logistic regression was used to assess the likelihood of pCR and Cox hazard analysis was used to assess OS. In total, 244 patients met inclusion criteria: 190 (77.9%) were non-diabetic and 54 (22.1%) were diabetic. Diabetic and non-diabetic patients were similar in age, sex, institution where they received treatment, ASA class, comorbidities, histologic sub-type, clinical T and N stage, chemotherapy regimen and radiation dose. Diabetic patients were more likely to have a higher body mass index (29.1 vs 25.9, p < 0.001) and hypertension (87.0% vs 47.9%, p < 0.001). On univariable analysis, diabetes was the only factor associated with decreased likelihood of pCR (p = 0.04). Multivariable analysis showed diabetes was again the only factor associated with a decreased likelihood of pCR (OR 0.32, p = 0.03). Cox survival analysis showed that older age (HR 1.03, p = 0.02) and overall posttreatment pathologic stage 2 (HR 2.16, p = 0.03), stage 3 (HR 3.25, p < 0.001), and stage 4 (HR 5.75, p < 0.001) compared to pCR were associated with worse OS, however diabetes alone had no effect (HR 1.01, p = 0.98). This multi-institutional study shows that diabetes adversely affects pCR in patients receiving neoadjuvant treatment for esophageal cancer. Almost a quarter of patients with esophageal cancer have diabetes suggesting implications for management of these patients. Future studies are warranted to determine the optimal neoadjuvant treatment strategy for esophageal cancer patients with diabetes." @default.
• W4214897071 created "2022-03-05" @default.
• W4214897071 creator A5022833468 @default.
• W4214897071 creator A5044479095 @default.
• W4214897071 creator A5075048620 @default.
• W4214897071 creator A5076869180 @default.
• W4214897071 creator A5083024748 @default.
• W4214897071 creator A5091585187 @default.
• W4214897071 date "2023-01-01" @default.
• W4214897071 modified "2023-10-14" @default.
• W4214897071 title "The Effect of Diabetes on Pathologic Complete Response Among Patients With Esophageal Cancer" @default.
• W4214897071 cites W1493323586 @default.
• W4214897071 cites W1978281808 @default.
• W4214897071 cites W1993961359 @default.
• W4214897071 cites W2017407100 @default.
• W4214897071 cites W2038961236 @default.
• W4214897071 cites W2066292153 @default.
• W4214897071 cites W2070055913 @default.
• W4214897071 cites W2100394877 @default.
• W4214897071 cites W2103246760 @default.
• W4214897071 cites W2136935697 @default.
• W4214897071 cites W2154444715 @default.
• W4214897071 cites W2234784039 @default.
• W4214897071 cites W2399421418 @default.
• W4214897071 cites W2753811612 @default.
• W4214897071 cites W2900847413 @default.
• W4214897071 cites W2950854391 @default.
• W4214897071 cites W2965636231 @default.
• W4214897071 cites W2999422616 @default.
• W4214897071 cites W3083889122 @default.
• W4214897071 cites W3089269132 @default.
• W4214897071 doi "https://doi.org/10.1053/j.semtcvs.2021.10.016" @default.
• W4214897071 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35248723" @default.
• W4214897071 hasPublicationYear "2023" @default.
• W4214897071 type Work @default.
• W4214897071 citedByCount "3" @default.
• W4214897071 countsByYear W42148970712022 @default.
• W4214897071 countsByYear W42148970712023 @default.
• W4214897071 crossrefType "journal-article" @default.
• W4214897071 hasAuthorship W4214897071A5022833468 @default.
• W4214897071 hasAuthorship W4214897071A5044479095 @default.
• W4214897071 hasAuthorship W4214897071A5075048620 @default.
• W4214897071 hasAuthorship W4214897071A5076869180 @default.
• W4214897071 hasAuthorship W4214897071A5083024748 @default.
• W4214897071 hasAuthorship W4214897071A5091585187 @default.
• W4214897071 hasConcept C121608353 @default.
• W4214897071 hasConcept C126322002 @default.
• W4214897071 hasConcept C134018914 @default.
• W4214897071 hasConcept C143998085 @default.
• W4214897071 hasConcept C207103383 @default.
• W4214897071 hasConcept C2777297899 @default.
• W4214897071 hasConcept C2778292576 @default.
• W4214897071 hasConcept C2779159551 @default.
• W4214897071 hasConcept C2779742542 @default.
• W4214897071 hasConcept C2781413609 @default.
• W4214897071 hasConcept C44249647 @default.
• W4214897071 hasConcept C50382708 @default.
• W4214897071 hasConcept C509974204 @default.
• W4214897071 hasConcept C530470458 @default.
• W4214897071 hasConcept C555293320 @default.
• W4214897071 hasConcept C71924100 @default.
• W4214897071 hasConcept C90924648 @default.
• W4214897071 hasConceptScore W4214897071C121608353 @default.
• W4214897071 hasConceptScore W4214897071C126322002 @default.
• W4214897071 hasConceptScore W4214897071C134018914 @default.
• W4214897071 hasConceptScore W4214897071C143998085 @default.
• W4214897071 hasConceptScore W4214897071C207103383 @default.
• W4214897071 hasConceptScore W4214897071C2777297899 @default.
• W4214897071 hasConceptScore W4214897071C2778292576 @default.
• W4214897071 hasConceptScore W4214897071C2779159551 @default.
• W4214897071 hasConceptScore W4214897071C2779742542 @default.
• W4214897071 hasConceptScore W4214897071C2781413609 @default.
• W4214897071 hasConceptScore W4214897071C44249647 @default.
• W4214897071 hasConceptScore W4214897071C50382708 @default.
• W4214897071 hasConceptScore W4214897071C509974204 @default.
• W4214897071 hasConceptScore W4214897071C530470458 @default.
• W4214897071 hasConceptScore W4214897071C555293320 @default.
• W4214897071 hasConceptScore W4214897071C71924100 @default.
• W4214897071 hasConceptScore W4214897071C90924648 @default.
• W4214897071 hasIssue "2" @default.
• W4214897071 hasLocation W42148970711 @default.
• W4214897071 hasLocation W42148970712 @default.
• W4214897071 hasOpenAccess W4214897071 @default.
• W4214897071 hasPrimaryLocation W42148970711 @default.
• W4214897071 hasRelatedWork W2052439835 @default.
• W4214897071 hasRelatedWork W2083004981 @default.
• W4214897071 hasRelatedWork W2084845148 @default.
• W4214897071 hasRelatedWork W2275543989 @default.
• W4214897071 hasRelatedWork W2395280816 @default.
• W4214897071 hasRelatedWork W2752955488 @default.
• W4214897071 hasRelatedWork W2762154826 @default.
• W4214897071 hasRelatedWork W2914727338 @default.
• W4214897071 hasRelatedWork W2921693759 @default.
• W4214897071 hasRelatedWork W3004241701 @default.
• W4214897071 hasVolume "35" @default.
• W4214897071 isParatext "false" @default.
• W4214897071 isRetracted "false" @default.
• W4214897071 workType "article" @default.